A novel plasmid DNA electroporation method allows transfection of murine DC

Journal of Immunological Methods

Volumn 343, Issue 1, 2009, Pages 13-20

  Bros, Matthias ^a   Wiechmann, Nadine ^a   Besche, Verena ^a   Castor, Timo ^a   Sudowe, Stephan ^a   Grabbe, Stephan ^a   Reske Kunz, Angelika B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Dendritic cells; Electroporation; Immune response; Tolerogenic phenotype

Indexed keywords

INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL FUNCTION; DENDRITIC CELL; DEVICE; DNA TRANSFECTION; ELECTROPORATION; FEMALE; LYMPHOCYTE PROLIFERATION; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENETIC VECTORS; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; PLASMIDS; TRANSFECTION; TRANSGENES;

MURINAE;

EID: 60649102087     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.01.006     Document Type: Article

References (31)

1. Adams S., O'Neill D.W., and Bhardwaj N. Recent advances in dendritic cell biology. J. Clin. Immunol. 25 (2005) 87
2. Akbari O., and Umetsu D.T. Role of dendritic cells in allergy and asthma. Curr. Opin. Allergy Clin. Immunol. 4 (2004) 533
3. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003) 1073
4. Breckpot K., Heirman C., Neyns B., and Thielemans K. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells. J. Gene Med. 6 (2004) 1175
5. Bros M., Ross X.-L., Pautz A., Reske-Kunz A.B., and Ross R. The human fascin gene promoter is highly active in mature dendritic cells due to a stage-specific enhancer. J. Immunol. 171 (2003) 1825
6. Bros M., Jährling F., Renzing A., Wiechmann N., Dang N.A., Sutter A., Ross R., Knop J., Sudowe S., and Reske-Kunz A.B. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 109 (2007) 3820
7. Chamarthy S.P., Jia L., Kovacs J.R., Anderson K.R., Shen H., Firestine S.M., and Meng W.S. Gene delivery to dendritic cells facilitated by a tumor necrosis factor alpha-competing peptide. Mol. Immunol. 41 (2004) 741
8. Chen D., Sung R., and Bromberg J.S. Gene therapy in transplantation. Transpl. Immunol. 9 (2002) 301
9. Cotten M., Baker A., Saltik M., Wagner E., and Buschle M. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther. 1 (1994) 239
10. Denis-Mize K.S., Dupuis M., MacKichan M.L., Singh M., Doe B., O'Hagan D., Ulmer J.B., Donnelly J.J., McDonald D.M., and Ott G. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther. 7 (2000) 2105
11. Diebold S.S., Kursa M., Wagner E., Cotten M., and Zenke M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. 274 (1999) 19087
12. Figdor C.G., de Vries I.J., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10 (2004) 475
13. Garrigan K., Moroni-Rawson P., McMurray C., Hermans I., Abernethy N., Watson J., and Ronchese F. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 88 (1996) 3508
14. Ghadially H., Ross X.L., Kerst C., Dong J., Reske-Kunz A.B., and Ross R. Differential regulation of CCL22 gene expression in murine dendritic cells and B cells. J. Immunol. 174 (2005) 5620
15. Irvine A.S., Trinder P.K., Laughton D.L., Ketteringham H., McDermott R.H., Reid S.C., Haines A.M., Amir A., Husain R., Doshi R., Young L.S., and Mountain A. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat. Biotechnol. 18 (2000) 1273
16. Ishii K., and Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27 (2006) 525
17. Kikuchi T. Genetically modified dendritic cells for therapeutic immunity. Tohoku J. Exp. Med. 208 (2006) 1
18. Lee Y., Sohn W.J., Kim D.S., and Kwon H.J. NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur. J. Biochem. 271 (2004) 1094
19. Lutz M.B., and Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 23 (2002) 445
20. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77
21. Neumann M., Fries H., Scheicher C., Keikavoussi P., Kolb-Mauerer A., Brocker E., Serfling E., and Kampgen E. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95 (2000) 277
22. Ross R., Sudowe S., Beisner J., Ross X.-L., Ludwig-Portugall I., Steitz J., Tüting T., Knop J., and Reske-Kunz A.B. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther. 10 (2003) 1035
23. Scheicher C., Mehlig M., Zecher R., and Reske K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154 (1992) 253
24. Schottelius A.J., Mayo M.W., Sartor R.B., and Baldwin A.S. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 274 (1999) 31868
25. Smits H.H., de Jong E.C., Wierenga E.A., and Kapsenberg M.L. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26 (2005) 123
26. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99 (2002) 2468
27. Sudowe S., Ludwig-Portugall I., Montermann E., Ross R., and Reske-Kunz A.B. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Molec. Ther. 8 (2003) 567
28. Van Meirvenne S., Straetman L., Heirman C., Dullaers M., De Greef C., Van Tendeloo V., and Thielemans K. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther. 9 (2002) 787
29. + subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur. J. Immunol. 34 (2004) 2800
30. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605
31. Zal T., Volkmann A., and Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180 (1994) 2089